Physician profile
Asif Aziz
NPI 1922194992
$1,027.57
in general payments reported to CMS, 2019-2025
23 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2021: $34.01 · 2022: $91.91 · 2023: $227 · 2024: $260 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $322.19 | 2024-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Abbvie INC. | $108.65 | 2021-2024 | Vraylar |
| Teleflex LLC | $80.00 | 2023 | Urolift |
| Glaxosmithkline, LLC. | $58.01 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $57.76 | 2019 | |
| Si-Bone, INC. | $56.87 | 2019 | |
| Novo Nordisk INC | $48.56 | 2019-2023 | Ozempic, Rybelsus |
| Renalytix Ai, INC. | $43.34 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Abbott Laboratories | $32.54 | 2021-2023 | Freestyle Libre 3 |
| Kerecis Limited | $27.51 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Cardiovascular Systems INC. | $22.75 | 2019 | |
| Astellas Pharma US INC | $20.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.54 | 2023 | |
| Lilly USA, LLC | $16.52 | 2024 | Zepbound |
| Medtronic USA, INC. | $16.02 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.56 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.09 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.73 | 2022 | |
| Dexcom, INC. | $14.17 | 2022 | |
| Ironwood Pharmaceuticals, INC | $13.62 | 2019 | |
| Argon Medical Devices, INC. | $13.51 | 2024 | Clot Management |
| Shire North American Group INC | $11.50 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asif Aziz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.